BMJ Open10 Feb 2025
A clinical trial aims to determine if a loading dose of cefoxitin followed by continuous infusion reduces surgical site infections (SSIs) in colorectal surgery compared to intermittent bolus administration. Conducted across multiple centers with 2000 patients, the study seeks to demonstrate that this alternative administration…
JAMA Netw Open9 Feb 2025
A study involving 1,254 participants revealed that an automatic quality control system (AQCS) significantly improved adenoma detection rates during routine colonoscopy. The AQCS-assisted group achieved a detection rate of 32.7% compared to 22.6% in the standard group (relative risk 1.60, p
Front Med (Lausanne)9 Feb 2025
Advanced machine learning techniques, particularly the xgboost algorithm, have shown exceptional predictive accuracy for identifying the risk of postoperative gastroparesis in colon cancer patients after complete mesocolic excision. From a cohort of 1,097 patients, featuring 87 gastroparesis cases, xgboost achieved an area under the curve…
Int J Surg8 Feb 2025
In a prospective study involving 587 colorectal cancer patients, non-enhanced abbreviated MRI (ne-amri) demonstrated superior diagnostic accuracy for liver metastases detection compared to contrast-enhanced CT (ce-ct). Across three surveillance rounds, ne-amri consistently showed higher lesion-based detection rates and better patient-based metrics, including sensitivity and specificity.…
Intestine and Lower Gastrointestinal Tract7 Feb 2025
A systematic review of 37 studies involving 4,647 patients revealed that chewing gum, electroacupuncture, and prokinetic agents significantly reduce the time to passage of the first flatus and stool, thereby mitigating postoperative ileus. Electroacupuncture reduced flatus passage by an impressive 18.33 hours, while prokinetic agents…
J Surg Oncol7 Feb 2025
A tumor-informed circulating tumor DNA (ctDNA) assay was found to be highly prognostic for recurrence risk in stage III colorectal cancer patients. Among 124 patients analyzed over a median follow-up of 4.8 years, ctDNA status exhibited a significant association with recurrence-free survival. The estimated 3-year…
J Surg Res6 Feb 2025
A study involving 47,960 patients aimed to compare postoperative outcomes for colectomies regarding nonmalignant polyps (NMP) and colon cancer, revealing no significant differences in mortality, reoperation, and anastomotic leak rates. Specifically, mortality was 0.6% for colon cancer and 0.5% for NMP, while anastomotic leak rates…
Int J Surg6 Feb 2025
A bibliometric study of 1,608 articles from 1994 to 2024 highlights the evolving landscape of anal fistula treatment in Crohn's disease. Researchers identified significant contributions from 325 countries, with the US and UK leading in publication volume. The Cleveland Clinic and Imperial College London emerged…
Intestine and Lower Gastrointestinal Tract5 Feb 2025
A novel bismuth subgallate-borneol compound ointment significantly improved wound healing in infectious postoperative wounds after anorectal surgery. In a randomized controlled trial involving 46 patients, the experimental group showed a higher granulation growth rate at all observation points and a notable increase in wound healing…
Eur J Surg Oncol4 Feb 2025
A prospective study of 56 colorectal cancer patients reveals that preoperative circulating tumor DNA (meth-ctDNA) serves as a significant biomarker for assessing treatment plans. Negative preoperative meth-ctDNA correlates with longer median progression-free survival (PFS), identified as a strong independent predictor (HR=3.3). Similarly, negative postoperative meth-ctDNA…